% | $
Quotes you view appear here for quick access.

Pharmacyclics, Inc. Message Board

  • popeyethesailor61 popeyethesailor61 Jan 22, 2013 8:08 PM Flag

    Best science - -ibrutnib -J&J cc

    Ibrutnib, an oral anticancer compound that we are developing in collaboration with Pharmacyclics for B cell malignancies, is another instance of accessing the best science to serve an unmet need. We’ve seen compelling early efficacy and safety data in multiple B cell malignancies, and have initiated a comprehensive global development program.

    Now in addition to the U.S. and E.U., this includes parallel development in China and Japan, and over the last 12 months, we’ve initiated three chronic lymphocytic leukemia Phase III studies and one Phase III in mantle cell lymphoma that is also ongoing, as well as a number of other earlier studies in B cell malignancies.

    Sentiment: Strong Buy

257.100.00(0.00%)Apr 23 3:59 PMEDT